Article Details
Retrieved on: 2021-01-04 17:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's Evrysdi (risdiplam) was approved on August 10 by the FDA for spinal muscular atrophy (SMA) in adults and children two months of age and ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here